0001567619-21-001460.txt : 20210125
0001567619-21-001460.hdr.sgml : 20210125
20210125171733
ACCESSION NUMBER: 0001567619-21-001460
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200119
FILED AS OF DATE: 20210125
DATE AS OF CHANGE: 20210125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arnold Mitchell
CENTRAL INDEX KEY: 0001841497
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39752
FILM NUMBER: 21550762
MAIL ADDRESS:
STREET 1: 200 ROUTE 9 NORTH
STREET 2: SUITE 500
CITY: MANALAPAN
STATE: NJ
ZIP: 07726
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Petros Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001815903
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851410058
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5301 WISCONSIN AVENUE NW
STREET 2: SUITE 570
CITY: WASHINGTON
STATE: DC
ZIP: 20015
BUSINESS PHONE: 301-215-7440
MAIL ADDRESS:
STREET 1: 5301 WISCONSIN AVENUE NW
STREET 2: SUITE 570
CITY: WASHINGTON
STATE: DC
ZIP: 20015
3
1
doc1.xml
FORM 3
X0206
3
2020-01-19
0
0001815903
Petros Pharmaceuticals, Inc.
PTPI
0001841497
Arnold Mitchell
1185 AVENUE OF THE AMERICAS, 3RD FLOOR
NEW YORK
NY
10036
0
1
0
0
Prin. Acct. Off/Prin. Fin. Off
Common Stock, par value $0.0001 per share
779
D
Common Stock, par value $0.0001 per share
390
I
See Footnote
The shares of common stock of Petros Pharmaceuticals, Inc. are directly held by Metuchen Therapeutics, LLC ("MT"). The Reporting Person holds an ownership percentage of 0.1% of MT.
/s/ Mitchell Arnold
2021-01-25